GlaxoSmithKline Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 32,780.3 million compared to INR 29,256 million a year ago. Revenue was INR 33,538.1 million compared to INR 30,361.8 million a year ago. Net income was INR 16,947.2 million compared to INR 3,581.5 million a year ago. Basic earnings per share from continuing operations was INR 22.48 compared to INR 16.96 a year ago. Basic earnings per share was INR 100.04 compared to INR 21.14 a year ago.